openPR Logo
Press release

Neurological Biomarkers Market Foreseen to Grow Exponentially Over 2018-2025

03-19-2019 09:57 AM CET | Health & Medicine

Press release from: Allied Market Research

Neurological Biomarkers Market

Neurological Biomarkers Market

According to a new report published by Allied Market Research, titled, Customized Study on Neurological Biomarkers Market for Alzheimers and Parkinsons Disease: Global Opportunity Analysis and Industry Forecast, 2017-2025, the global market was valued at $3,958.5 million in 2017, and is projected to reach $8,579.9 million by 2025, growing at a CAGR of 10.1% from 2018 to 2025. China accounted for one-ninth share of the total market of neurological biomarkers for Alzheimers in 2017.

The major companies profiled in this report include Abbott Laboratories, Myriad RBM, Proteome Sciences, Thermo Fisher Scientific, Athena Diagnostics, Immunarray Pvt. Ltd.,

Quanterix Corporation, Diagenic ASA, Psynova Neurotech, and Bio-Rad Laboratories. Other prominent players in the value chain include Qiagen, AbaStar MDx, Acumen Pharmaceuticals, Abiant, Alseres Pharmaceuticals, Athena Diagnostics, Banyan Biomarkers, and ProteoSys AG.

Increase in demand for noninvasive neurological biomarkers is expected to supplement the market growth. Furthermore, rise in number of research activities focused towards developing efficient biomarkers that can aid in early diagnosis of Alzheimer‐™s and Parkinson‐™s diseases is expected to drive the market growth in the near future. For instance, MSDx, Inc. is developing cost-effective and reliable blood-based neurological biomarkers that can aid in detecting the onset of disease before excessive damage occurs. The company has patented the blood test and has named it as the ‐Window into The Brain

Download Sample PDF Brochure of Neurological Biomarkers Market at: https://www.alliedmarketresearch.com/request-sample/3555

The neurological biomarkers market for Alzheimers disease generated a revenue of $2,636.7 million in 2017, and is expected to reach $6,122.5 million by 2025, registering a CAGR of 11.1% from 2018 to 2025. Conversely, neurological biomarkers market for Parkinsons disease generated a revenue of $1,321.8 million in 2017, and is expected to reach $2,457.4 million by 2025 registering a CAGR of 8.0%.

Upsurge in the incidence of Alzheimers and Parkinsons diseases is anticipated to contribute to the robust growth of neurological biomarkers. In addition, increase in adoption of neurological biomarkers in drug development and validation has been witnessed over the years to improve the accuracy of clinical trials. Furthermore, rise in preference towards personalized medicine is expected to offer profitable opportunities for the expansion of neurological biomarkers applied across Alzheimers and Parkinsons.

Based on the region, the neurological biomarkers market for Alzheimers and Parkinsons diseases is studied across the U.S., EU5, rest of Europe, China, Asia-Pacific, and rest of the world (ROW). The U.S. dominated the market for Alzheimers and Parkinsons in 2017, and is expected to continue this trend throughout the forecast period. In addition, Asia-Pacific is anticipated to grow at the fastest pace in Alzheimers neurological biomarkers market during the forecast period, whereas China is expected to register highest growth rate from 2018 to 2025 in the Parkinsons neurological biomarkers market.

Buy Now at: https://www.alliedmarketresearch.com/checkout/574473

About us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:
David C
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Neurological Biomarkers Market Foreseen to Grow Exponentially Over 2018-2025 here

News-ID: 1661463 • Views: 475

More Releases from Allied Market Research

Commercial Avionics Systems Market: Latest Industry Trends, Trades, Supply, Dema …
Commercial Avionics Systems Market Report, published by Allied Market Research, states that the commercial avionics systems market was valued at $16 billion in 2014 and is projected to reach $26 billion by 2022, growing at a CAGR of 7.1% from 2016 to 2022. Access Full Summary at: https://www.alliedmarketresearch.com/commercial-avionics-systems-market Surge in the number of aircraft deliveries, increasing demand for real-time data, economic growth in emerging countries, and increasing demand for in-flight entertainment (IFE)
Aerospace Robotics Market Comprehensive Evaluation with CAGR value of 17.2% duri …
Aerospace Robotics Market Report, published by Allied Market Research, projects that the global aerospace robotics market is expected to reach $5,687 million by 2022, growing at a CAGR of 17.2% from 2016 to 2022. The articulated robot segment is expected to dominate the global market during the forecast period. North America is expected to generate the maximum revenue in the global market by 2022. Access Full Summary at: https://www.alliedmarketresearch.com/aerospace-robotics-market The robotics technology
Smart Weapons Market Growth Forecast Through 2014-2022 With Upcoming Trends and …
Smart Weapons Market Report, published by Allied Market Research, projects that the smart weapons market size is expected to reach $99,380 million by 2022, growing at a CAGR of 11.6% from 2016 to 2022. This is attributed to the increase in defense expenditure by the governments paired with rising demand for precision strike weapons. North America is expected to be the largest market during the forecast period 2016-2022. Access Full Summary
Automotive Electronic Control Unit (ECU) Market is Projected to Reach US$ 749.6 …
According to a new report published by Allied Market Research, titled, Automotive Electronic Control Unit Market by Technology and Application: Global Opportunity Analysis and Industry Forecast, 2014-2022, the global automotive electronic control unit (AECU) market is estimated to reach $49,893 million by 2022 from $32,054 million in 2015. Asia-Pacific accounted for the highest share in 2015, and is anticipated to maintain its dominance throughout the forecast period. Access Full Summary at:

All 5 Releases


More Releases for Alzheimers

Rugged Expansion Foreseen by Alzheimers Disease Market
ResearchMoz include new market research report "Frontier Pharma: Alzheimers Disease and Associated Indications - Exceptional Level of First-in-Class Innovation within AD, and Diverse Range of Therapies in Development for Disorders Such as Anxiety and Depression" to its huge collection of research reports. Alzheimer’s disease (AD), the most common form of dementia, is a progressive, neurodegenerative and currently incurable disease characterized by loss of memory and other mental abilities. It has a
Alzheimers Disease Therapeutics Market Scenario Highlighting Major Drivers & Tre …
Alzheimer’s disease is a neurodegenerative, progressive, non-reversible disorder. Alzheimer’s disease is caused due to abnormal functioning of brain cells i.e. failure of synaptic transmission, resulting in the loss of cognitive functions. Some of the signs and symptoms of alzheimer’s disease are memory loss, insomnia, repetitive movements, agitation, anxiety, depression and loss of reasoning abilities. All memory and mental functioning may be lost in advanced stages of the disease. Alzheimer’s disease
Alzheimers Drug Market Size, Share and Forecast till 2022
Alzheimers Drug Report by Material, Application, and Geography - Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Request Sample Copy of the Business Report @ https://www.worldwidemarketreports.com/sample/26138 The report firstly introduced the Alzheimers Drug basics: definitions, classifications, applications and
Alzheimers Disease - Heat Map and Analysis
Albany, NY, Feb 27, 2017: Alzheimers disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. The pathological features of AD comprise a complex set of histopathological changes within the brain. Symptoms typically begin to first appear in patients in their mid-sixties, and appear in varying stages. The effects of AD, particularly at an advanced stage, are devastating to patients and their caregivers,
Alzheimers Disease - Heat Map And Analysis
MarketResearchReports.Biz is providing you Latest Market Research report of "Alzheimers Disease - Heat Map And Analysis". Alzheimers disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss and functional decline. The pathological features of AD comprise a complex set of histopathological changes within the brain. Symptoms typically begin to first appear in patients in their mid-sixties, and appear in varying stages. The effects of AD, particularly at
Overview Alzheimers Disease Heat Map and Analysis
Albany, New York, January 16, 2017: The latest report focusing on the Pharmaceutical Market has been recently added to the online database of Market Research Hub’s repository. The report covers the present scenario and the growth prospects of the Health Market. It is entitled as “Alzheimers Disease - Heat Map and Analysis”. Request for Sample Report: http://www.marketresearchhub.com/enquiry.php?type=S&repid=915814 Alzheimers disease (AD) is an irreversible, progressive neurodegenerative disease, characterized by cognitive impairment, memory loss